Monday, 23 September 2019

Japan News

  • Astellas, Merck enter co-promotion deal in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreement for ipragliflozin L-proline, a SGLT2 inhibitor, in Japan. Earlier ...Read more

  • Leading CMO to increase customer base in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, and Innomedica, a life sciences busi...Read more

  • Eisai to launch Bi Chocola Collagen and Bi Chocola Collagen Gelée

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Eisai will launch the tablet-type Bi Chocola Collagen and gelée drink-type Bi Chocola Collagen Gelée (both classified by Japan's Ministry of Health, Labour and Welfare as ...Read more

  • Astellas, UCB announce approval of Cimzia in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: Astellas Pharma and UCB announced that UCB Japan has received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cimzia (INN;certolizumab pego...Read more

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • New VP for Government affairs at Astellas

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

    Singapore: Mr Marty Golden will be joining Astellas as the new vice president of Government Affairs with effect from July 1, 2014, the company announced. Mr Golden will be leading Federal ...Read more

  • Sucampo, Abbott launch Amitiza in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Sucampo Pharmaceuticals and Abbott have launched Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases...Read more

  • Takeda gets Japanese NDA approval for obesity drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labour and Welfare approval for the new drug application (NDA) of Oblean ...Read more

  • Vifor and Zeria sign deal for Ferinject in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Swiss-based Vifor Pharma, a company of the Galenica Group, has entered into an exclusive licensing agreement with Zeria Pharmaceutical for the development and commercialization o...Read more

  • Takeda's diabetes drug gets Chinese FDA nod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has issued them an Import Drug License (IDL) for Nesina (alopliptin) for ...Read more

  • Aveo, Astellas report cancer trial results

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III TIVO-1 (Tivozanib versus sorafenib in first line adv...Read more

  • Top pharma deals in the last 5 years in APAC

    Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre-downturn levels. This is in line with the recovery made by the pharm...Read more

  • Thailand, Japan collaborate on bioremediation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

    Singapore: BIOTEC, NITE Biological Resource Center (NBRC) and Faculty of Science, Chulalongkorn University signed a project agreement to collaborate on "Assessment of microbial community...Read more

  • Japan, Singapore to bring innovation in drug, device, technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Science, Technology and Research (A*Star), the National University of Singa...Read more

  • Takeda enters into supply agreement for Omontys

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Takeda and Affymax, announced that Takeda Pharmaceuticals America (TPA) has entered into a supply agreement for sourcing and supply of Omontys (peginesatide) injection with DSI ...Read more

  • Japanese, Thai institutes sign bio-conservation MoU

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: A phase III memorandum of understanding (MoU) was signed between Thailand's BIOTEC and Japan's National Institute of Technology and Evaluation (NITE) on October 24, 2012, at the ...Read more

  • Takeda receives Japanese nod for Adcetris

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2014

    Singapore: Japanese pharma major Takeda Pharma has announced that it has received approval of Adcetris (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare (MHLW)....Read more

  • Verastem enters research collaboration with Eisai

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2012

    Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced a research collabora...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls